(FM) Inmunología
Departamento académico
Università di Perugia
Perugia, ItaliaPublicaciones en colaboración con investigadores/as de Università di Perugia (3)
2024
2023
-
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Journal of Clinical Oncology, Vol. 41, Núm. 2, pp. 212-221
2010
-
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009
Cancer Immunology, Immunotherapy